Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations.

MLA

Bouffet, Eric, et al. “Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations.” New England Journal of Medicine, vol. 389, no. 12, Sept. 2023, pp. 1108–20. EBSCOhost, https://doi.org/10.1056/NEJMoa2303815.

APA

Bouffet, E., Hansford, J. R., Garrè, M. L., Junichi Hara, Plant-Fox, A., Aerts, I., Locatelli, F., van der Lugt, J., Papusha, L., Sahm, F., Tabori, U., Cohen, K. J., Packer, R. J., Witt, O., Sandalic, L., Pereira da Silva, A. B., Russo, M., & Hargrave, D. R. (2023). Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations. New England Journal of Medicine, 389(12), 1108–1120. https://doi.org/10.1056/NEJMoa2303815

Chicago

Bouffet, Eric, Jordan R. Hansford, Maria Luisa Garrè, Junichi Hara, Ashley Plant-Fox, Isabelle Aerts, Franco Locatelli, et al. 2023. “Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations.” New England Journal of Medicine 389 (12): 1108–20. doi:10.1056/NEJMoa2303815.